![](/img/cover-not-exists.png)
PMH55 CANADIAN COST-EFFECTIVENESS ANALYSIS OF LONG-ACTING RISPERIDONE VERSUS ORAL ATYPICAL AND CONVENTIONAL DEPOT ANTIPSYCHOTICS IN PATIENTS WITH SCHIZOPHRENIA AT HIGH-RISK OF NON-COMPLIANCE: UPDATED BASED ON NEW CLINICAL DATA
Lam, A, Heeg, BVolume:
13
Language:
english
Journal:
Value in Health
DOI:
10.1016/S1098-3015(10)72550-X
Date:
May, 2010
File:
PDF, 76 KB
english, 2010